Pathology of Melanocytic Tumors

  • ID: 4519506
  • Book
  • 432 Pages
  • Elsevier Health Science
1 of 4

Constituting a large percentage of everyday diagnostic practice, melanocytic pathology is a complex and challenging area with many difficult-to-diagnose lesions. This highly illustrated reference, written by three of the world's leading dermatopathologists, provides authoritative guidance in the accurate diagnosis of even the most challenging pigmented skin tumors, helping you avoid pitfalls and recognize mimics.

Note: Product cover images may vary from those shown
2 of 4
Section I Benign Cutaneous Melanocytic Proliferations

1. Melanotic Macules

2. Acquired Melanocytic Nevi

3. Congenital Melanocytic Nevi

4. Spitz Nevi

5. Blue Nevi and Dermal Melanocytosis

6. Deep Penetrating Nevi

7. Nevi of Special Cutaneous Sites

8. Traumatized and Recurrent Melanocytic Nevi, and Nevi Changing under Treatment

9. Combined Melanocytic Nevi

10. Pigmented Epithelioid Melanocytoma

Section II Primary Cutaneous Melanoma

11. Histopathologic Fiagnosis of Melanoma

12. Lentigo Maligna Melanoma

13. Superficial Spreading Melanoma

14. Acral and Subungual Melanoma

15. Nodular Melanoma

16. Desmoplastic Melanoma

17. Nevoid Melanoma

18. Spitzoid Melanoma

19. Melanoma Arising in Association with or Simulating a Blue Nevus

20. Uncommon Variants of Melanoma

21. Pediatric Melanoma

Section III Primary Extracutaneous Melanocytic Proliferations

22. Conjunctival Melanocytic Proliferations

23. Melanocytic Proliferations of the Uveal Tract

24. Mucosal Melanocytic Tumors

25. Primary Melanocytic Neoplasms of the Central Nervous System and Melanotic Schwannoma

26. Melanocytic nevi in Lymph Nodes

Section IV Metastatic Melanoma

27. Metastatic Melanoma

Section V Ancillary Studies

28. Dermoscopy for Dermatopathologists

29. Immunohistochemistry for the Diagnosis of Melanocytic Proliferations

30. Molecular Techniques

31. Clinical, Dermoscopic, Pathologic and Molecular Correlations

Section VI Prognosis, Staging, and Reporting of Melanoma

32. Prognosis, Staging, and Reporting of Melanoma

Section VII Margin Assessment of Melanomas

33. Margin Assessment of Cutaneous Melanoma
Note: Product cover images may vary from those shown
3 of 4


4 of 4
Busam, Klaus J. Professor of Pathology and Laboratory Medicine, Weill Medical College of Cornell University; Director of Dermatopathology, Department of Pathology, Memorial Sloan-Kettering Cancer Center, New York, New York, USA.

Gerami, Pedram Professor of Dermatology and Pathology, Director of the Skin Cancer Institute of Northwestern Medicine (SCIN-med) Director of the Melanoma Program of SCIN-med Northwestern University Department of Dermatology and the Lurie Cancer Center.

Scolyer, Richard A Co-Director of Research, Melanoma Institute Australia; Senior Staff Specialist,Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital; Clinical Professor, Sydney Medical School, The University of Sydney, Sydney, Australia.
Note: Product cover images may vary from those shown
5 of 4
Note: Product cover images may vary from those shown